Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...

Unique Battery Metals opportunity in Quebec

Coniagas Battery Metals Inc (TSXV:V.COS ), a Canadian Junior Mining Company focused on nickel, copper, cobalt and platinum group metals in Quebec. The Market Online recently sat down again with CEO and Director, Frank Basa The following is a transcription of the abo...

Level up your trading with BMO InvestorLine’s enhanced features

With about 48 per cent of Canadians investing regularly, according to an Ipsos poll conducted in February, and more young people learning about the benefits of putting money to work than ever before, the demand for leading-edge trading platforms in terms of efficienc...

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

Bitcoin company adds convenience of modern banking

The following is a transcription of the above video, and The Market Online has edited it for clarity . Bitcoin Well Inc. (TSXV:BTCW) is a non-custodial fintech company, with a primary focus on empowering people to interact directly with the Bitcoin protocol. J...

BASF and Cardiol Therapeutics recommended buys; TUI rides momentum

BASF (OTCQX:BASFY) shares have gained over 30% within six months. But is the rally in BASF shares slowly running out of steam? The fact that the stock did not rise sharply yesterday despite a significant price target increase suggests this is the case. Many experts see ...

Desert Gold, Barrick, Intel: Will U.S. stagflation push gold higher?

Gold has reached another record level of over US$2,300 per ounce. Investors are betting that the U.S. Federal Reserve will cut interest rates later this year. Gold has been on an upward trend since mid-February. On the one hand, it has a reputation for maintaining or...

What is green steel and why is this iron project so attractive?

The following is a transcription of the above video, and The Market Online has edited it for clarity . The critical mineral exploration and development company Strategic Resources (TSXV:SR) continues to focus on its high-purity iron and vanadium projects in Canada...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
1 2 3 4 5 6 7 8 9 10 ...